FB2026_02 , released June 18, 2026
Human Disease Model Report: optic atrophy syndromes, OPA1-related
Open Close
General Information
Name
optic atrophy syndromes, OPA1-related
FlyBase ID
FBhh0000642
Disease Ontology Term
Parent Disease
OMIM
Overview

The human gene OPA1 is implicated in multiple diseases with a broad range of neurologic phenotypes (MIM:605290); common phenotypes include optic atrophy, other vision problems, hearing loss, and ataxia. The OPA1 gene encodes a protein that localizes to the inner mitochondrial membrane and that impacts mitochondrial fusion, apoptosis, reactive oxygen species production and ATP production. It has been postulated that retinal ganglion cells may be particularly vulnerable to mitochondrial dysfunction (Yu-Wai-Man et al., 2009; pubmed:19001017). There is a single orthologous gene in Drosophila, Dmel\Opa1, for which RNAi-targeting constructs and hypomorphic alleles caused by insertional mutagenesis have been generated.

Multiple UAS constructs of the human Hsap\OPA1 gene, including wild-type and variants implicated in disease, have been introduced into flies. See the 'Disease-Implicated Variants' table below. Partial heterologous rescue (functional complementation) has been demonstrated. Variants of Hsap\OPA1 implicated in disease fail to rescue or exhibit a lower degree of rescue. More severe mutations are associated with optic atrophy plus syndrome (FBhh0000645) and less severe with optic atrophy 1 (FBhh0000644); this analysis allows quantitative evaluation of loss-of-function severity by comparing the rescue capabilities of known or newly identified variants, thus allowing rapid determination of the disease subtype.

Animals homozygous for loss-of-functions mutations of Dmel\Opa1 die in the larval stage. Heterozygotes exhibit visual abnormalities and defects in mitochondrial morphology in muscle; degeneration of the optic nerve is observed. When targeted loss of function is effected by RNAi, fragmented mitochondria are frequently observed in the targeted tissue. Somatic clones, especially in the eye, have been used to further characterize loss-of-function phenotypes. Phenotypes of somatic clones and in heterozygous animals have been used to assess therapeutic candidates.

[updated Oct. 2024 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: optic atrophy syndromes, OPA1-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype
Genetics
Cellular phenotype and pathology
Molecular information

The OPA1 gene encodes a protein that localizes to the inner mitochondrial membrane and regulates several important cellular processes including stability of the mitochondrial network, mitochondrial bioenergetic output, and sequestration of proapoptotic cytochrome c oxidase molecules within the mitochondrial cristae spaces (summary by Yu-Wai-Man et al., 2010; pubmed:). [from MIM:605290; 2017.10.02]

External links
Disease synonyms
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

One to one (1 human to 1 Drosophila).

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Optic atrophy 1 (Opa1) encodes a dynamin-related GTPase that mediates fusion of the inner membrane of mitochondria. It usually works with the product of Marf to coordinately fuse both mitochondrial membranes. The product of Opa1 activity is regulated by proteolytic processing. [Date last reviewed: 2019-03-14]
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human OPA1 (1 Drosophila to 1 human). Dmel\Opa1 shares 52% identity and 69% similarity with the human gene.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (10 groups)
      protein-protein
      Interacting group
      Assay
      References
      cross-linking study, western blot
      anti bait coimmunoprecipitation, peptide massfingerprinting, western blot
      anti bait coimmunoprecipitation, peptide massfingerprinting
      anti bait coimmunoprecipitation, peptide massfingerprinting
      anti bait coimmunoprecipitation, western blot, peptide massfingerprinting
      anti bait coimmunoprecipitation, western blot, peptide massfingerprinting
      anti bait coimmunoprecipitation, peptide massfingerprinting
      anti tag coimmunoprecipitation, Identification by mass spectrometry
      anti bait coimmunoprecipitation, peptide massfingerprinting
      anti tag coimmunoprecipitation, anti tag western blot
      Alleles Reported to Model Human Disease (Disease Ontology) (14 alleles)
      Models Based on Experimental Evidence ( 6 )
      Modifiers Based on Experimental Evidence ( 6 )
      Models Based on Experimental Evidence ( 4 )
      Modifiers Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      References (13)